Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Maravai LifeSciences

This Pandemic Star Is Embroiled in CEO Drama

Maravai LifeSciences had to undo a recent CEO change due to a lawsuit. Luckily, the drama should be resolved quickly.

The Street

Did Maravai LifeSciences Deserve to Sell Off on CEO Transition?

The new CEO is a perfect fit for the company's growth plans. Sales will decline sharply anyway.

The Street

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 44 companies hit new 52-week lows.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Upgrades

Benzinga

Maravai LifeSciences: Q4 Earnings Insights

Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.